You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The findings indicate that rare genetic variants in cardiomyopathy-related genes may also contribute to more common forms of heart failure.
Researchers analyzed viral samples from Boston early in the pandemic to study transmission events, including at a large international conference held there.
The program received an IDE from the FDA this summer and plans to release its first batch of genetic data to the research community late next year.
The methods, both published in Nature Biotechnology this week, result in completely phased haplotypes, without the need for sequencing parental samples.
Researchers uncovered genetic loci that may influence why childhood cancer survivors of African ancestry are more likely to develop therapy-linked cardiomyopathy.
The study, which focused on Europeans, also highlighted a role for enhancers during embryonic development in determining facial features.
Patients who underwent SLCO1B1 testing were able to lower their cholesterol levels similarly to those who did not, indicating that testing does not cause harm.
Twenty-nine new studies highlight how time in space affects the human body, including effects on telomeres, mitochondria, and more.
A team led by researchers at University College London studied mutations in almost 47,000 viral genomes collected from patients worldwide.
NCI researchers performed a multi-platform study to elucidate the factors that can contribute to a patient's better-than-expected response to a drug.
Researchers are hoping to make the technology a success for the environment and human health while avoiding the biases that resulted from the debate over GMOs.
The Regeneron Genetics Center will provide whole-exome sequencing for 150,000 patients who will be able to opt-in to receive actionable results.
A two-stage genome-wide association study and meta-analysis highlighted 11 novel and six known risk loci and made it possible to dig into the biology of intracranial aneurysm.
The researchers said that the virus' genome can be classified in six major types, which are characterized by 14 signature single nucleotide variations.
For the quarter ended Sept. 30, the company reported $2.2 million in revenues, down from $3.3 million in Q3 of 2019 but beating the average Wall Street estimate.
Yale University researchers have developed a file-format manipulation approach to block access to certain variants to protect participants' sensitive information.
For the three months ended Sept. 30, the company reported $71.8 million in revenues, up from $61.2 million in Q3 2019 and beating the average Wall Street estimate.
An investigation of SARS-CoV-2 outbreaks on mink farms using WGS concluded that humans were infected with strains with an animal sequence signature.
The APOE-ε4 allele, a major genetic risk factor for Alzheimer's disease, conveys more risk among Cuban than other Latino populations, the analysis found.
Researchers built a systematic map of protein-drug interactions to investigate the behaviors of cancer cells and the dependencies of treatment responses.
New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.
According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.
The US National Institutes of Health has a new initiative to address structural racism in biomedical research.
In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.